Genetic association of telomere length, obesity and tobacoo smoking with idiopathic pulmonary fibrosis risk

被引:8
|
作者
Wu, Wenjuan [1 ]
Li, Chenghai [2 ,3 ]
Zhu, Xiaoming [4 ]
Liu, Xueya [5 ]
Li, Ping [6 ]
Wan, Ruijie [5 ]
Wu, Xinhui [7 ]
Chen, Song [8 ]
机构
[1] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Geriatr Med, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Stem cell program Clin Res Ctr, Peoples Hosp, Zhengzhou, Peoples R China
[3] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
[4] Henan Prov Peoples Hosp, Dept Thorac Surg, Zhengzhou, Peoples R China
[5] Henan Prov Peoples Hosp, Dept Geriatr Med, Zhengzhou, Peoples R China
[6] Zhengzhou Univ, Dept Resp & Crit Care Med, Affiliated Hosp 1, Zhengzhou, Peoples R China
[7] Zhengzhou Shuqing Med Coll, Dept Tradit Chinese Med, Zhengzhou, Peoples R China
[8] Zhengzhou Univ, Henan Prov Peoples Hosp, Translat Res Inst, Acad Med Sci, Zhengzhou, Peoples R China
关键词
Idiopathic pulmonary fibrosis; Mendelian randomization; Obesity; Telomere length; Tobacco smoking; MENDELIAN RANDOMIZATION;
D O I
10.1186/s12889-023-15733-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background Due to the inadequacy of published evidence, association of telomere length (TL), obesity and tobacco smoking with idiopathic pulmonary fibrosis (IPF) remains unclear. The aim of the study was to explore whether these exposures genetically affected the risk of the disease. Methods Genetic variants from genome-wide association studies for TL, body mass index (BMI), body fat percentage (BFP) and tobacco smoking (including maternal smoking) were used as instrumental variables. Inverse-variance weighted were mainly adopted to determine the genetic association of these exposures with IPF. All analyses were conducted by R-software (version 3.6.1). Results Firstly, longer TL was associated with the decreased risk of IPF (OR = 0.475 per SD increase in TL, 95%CI = 0.336 similar to 0.670, P<0.001). Secondly, higher levels of BMI and BFP were related to the increased risk of the disease (OR = 1.425 per SD increase in BMI level, 95%CI = 1.114 similar to 1.823, P = 0.005; OR = 1.702 per SD increase in BFP level, 95%CI = 1.202 similar to 2.409, P = 0.003). Thirdly, maternal smoking was implicated in the increased risk of the disease (OR = 13.183 per SD increase in the prevalence of maternal smoking, 95%CI = 1.820 similar to 95.484, P = 0.011). Conclusion TL should be a genetic risk factor for IPF. Obesity and exposure to tobacco smoking as a fetus might also contribute to the development of this fibrotic diseases. These findings should be verified by future studies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease
    Zhang, David
    Adegunsoye, Ayodeji
    Oldham, Justin M.
    Wolters, Paul J.
    Garcia, Christine Kim
    Newton, Chad A.
    EUROPEAN RESPIRATORY JOURNAL, 2024, 63 (01)
  • [32] Role of Telomere Length in Survival of Patients with Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
    Tesolato, Sofia
    Vicente-Valor, Juan
    Jarabo, Jose-Ramon
    Calatayud, Joaquin
    Saiz-Pardo, Melchor
    Nieto, Asuncion
    Alvaro-Alvarez, Dolores
    Linares, Maria-Jesus
    Fraile, Carlos-Alfredo
    Hernando, Florentino
    Iniesta, Pilar
    Gomez-Martinez, Ana-Maria
    BIOMEDICINES, 2023, 11 (12)
  • [33] Association of Obesity with Telomere Length in Human Sperm
    Moustakli, Efthalia
    Zikopoulos, Athanasios
    Skentou, Charikleia
    Dafopoulos, Stefanos
    Stavros, Sofoklis
    Dafopoulos, Konstantinos
    Drakakis, Peter
    Georgiou, Ioannis
    Zachariou, Athanasios
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)
  • [34] Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population
    Dai, Jinghong
    Cai, Hourong
    Zhuang, Yi
    Wu, Yongzheng
    Min, Haiyan
    Li, Jinheng
    Shi, Yi
    Gao, Qian
    Yi, Long
    RESPIROLOGY, 2015, 20 (01) : 122 - 128
  • [35] Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
    Michalski, Jacob E.
    Schwartz, David A.
    JOURNAL OF INFLAMMATION RESEARCH, 2020, 13 : 1305 - 1317
  • [36] Clinical use of telomere lenghth in idiopathic pulmonary fibrosis
    Muca, Trejsi
    Van Dievoet, Marie-Astrid
    Decottignies, Anabelle
    Froidure, Antoine
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [37] The Association of Telomere Length and Genetic Variation in Telomere Biology Genes
    Mirabello, Lisa
    Yu, Kai
    Kraft, Peter
    De Vivo, Immaculata
    Hunter, David J.
    Prescott, Jennifer
    Wong, Jason Y. Y.
    Chatterjee, Nilanjan
    Hayes, Richard B.
    Savage, Sharon A.
    HUMAN MUTATION, 2010, 31 (09) : 1050 - 1058
  • [38] Accelerated Decline in Peripheral Blood Telomere Length in Persons at Risk for Familial Pulmonary Fibrosis
    Salisbury, M. L.
    Ding, G.
    Markin, C. R.
    Douglas, K.
    Wu, P.
    Cogan, J. D.
    Mitchell, D.
    Young, L. R.
    Loyd, J. E.
    Lancaster, L. H.
    Kropski, J. A.
    Blackwell, T. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [39] The MUC5B Promoter Polymorphism and Telomere Length in Chinese Patients with Idiopathic Pulmonary Fibrosis
    Wang, H.
    Peng, H.
    Zhuang, Y.
    Cao, M.
    Li, Y.
    Zhou, K.
    He, J.
    Liang, G.
    Cai, H.
    Dai, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [40] From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis
    van Batenburg, Aernoud A.
    Kazemier, Karin M.
    van Oosterhout, Matthijs F. M.
    van der Vis, Joanne J.
    van Es, Hendrik W.
    Grutters, Jan C.
    Goldschmeding, Roel
    van Moorsel, Coline H. M.
    PLOS ONE, 2020, 15 (01):